Harvard Pulmonary and Critical Care Medicine 2025

• Target Audience: pulmonologists, critical care physicians, internists
• Sample video: contact me for sample video
• Information:

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures, and Challenging Cases

Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2025 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.

OVERVIEW

This comprehensive course provides education and updates to optimize your care of patients with:

IPF

ARDS

Sarcoidosis

Lung transplantation

Bronchiectasis

Cystic fibrosis

Lung nodules

Lung cancer

Sepsis

Pleural disease

Pneumonia

Tuberculosis

Thromboembolism

Chronic cough

COPD

Asthma

Occupational and environmental lung disease

Interstitial lung disease

GERD

Neurologic issues in the ICU

Sleep-disordered breathing

Post-acute sequelae of COVID-19

Surgical emergencies

Atypical mycobacterial disease

Pulmonary hypertension

Cardiopulmonary disorders

Complications from cardiac arrest

Hypersensitivity pneumonitis

Acute respiratory failure

REASONS TO ATTEND IN 2025

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:

The most current guidelines for treating sepsis

Evidence-based treatment of ARDS

State of the art in interventional pulmonology

High-flow oxygen therapy for respiratory failure

Updates on biologics in asthma and other lung disease

New concepts in the use of vasopressors in septic shock

New drugs and combinations in pulmonary hypertension

New evidence on sedation, analgesia, and early mobility in the ICU

Point-of-care pulmonary ultrasound in the intensive care unit

Lung microbiome: emerging implications for lung health

Emerging evidence for targeted temperature management

Evaluating occupational and environmental lung disease

Steroid-sparing agents for interstitial lung disease

Pulmonary embolus: the latest treatment strategies

State-of-the-art management of the critically ill patient

Guidance to conduct end-of-life discussions

Updates in pulmonary pathology

New treatment options in cystic fibrosis

Handling neurologic and surgical emergencies in the medical ICU

New approaches that improve outcomes for patients with unexplained chronic cough

Participants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.

Optional Half-Day Program

(No additional fees apply)

Sleep Medicine for Pulmonologists

This sleep medicine program provides pulmonologists the opportunity to learn about recent advances in Sleep Medicine and how they impact clinical practice.

Offered on Friday afternoon, May 2, participants of Pulmonology and Critical Care Medicine 2025 can participate in this half-day program at no additional cost.

Highlights of this practical, interactive educational experience include:

Updates for diagnosis and management of sleep-disordered breathing

State-of-the-art management algorithms

New technologies vs. the “gold standard” polysomnogram

Reimbursement and telemedicine

Improved adherence to therapy

Participants will leave with specific recommendations to improve the clinical care of patients with sleep disorders.

Interventional Pulmonology

This course covers advances in interventional pulmonology:

Diagnostic procedures

Therapeutic interventions

As an alternative to surgery

Who Should Attend

Pulmonologists

Critical Care Physicians

Internists

Nurse Practitioners

Physician Assistants

Residents and Fellows

Sleep Medicine for Pulmonologists

Optional Half-Day Program

Updates for diagnosis and management of sleep-disordered breathing

State-of-the-art management algorithms

New technologies vs. the “gold standard” polysomnogram

Reimbursement and telemedicine

Improved adherence to therapy

• Topics:

Day 1 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis.pdf

Day 1 Cystic Fibrosis Understanding CFTR and New Treatment.mp4

Day 1 Cystic Fibrosis Understanding CFTR and New Treatment.pdf

Day 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.mp4

Day 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.pdf

Day 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD.pdf

Day 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.mp4

Day 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.pdf

Day 1 GERD in Pulmonology.mp4

Day 1 GERD in Pulmonology.pdf

Day 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.mp4

Day 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.pdf

Day 1 Looking Deeper Patterns and Insights from Chest Radiology.mp4

Day 1 Looking Deeper Patterns and Insights from Chest Radiology.pptx

Day 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.mp4

Day 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.pdf

Day 1 Pulmonary Pathology Interstitial Lung Disease.mp4

Day 1 Pulmonary Pathology Interstitial Lung Disease.pdf

Day 1 Q & A Session with Speakers 1.mp4

Day 1 Q & A Session with Speakers 2.mp4

Day 1 Treatment Challenges of Pulmonary Sarcoidosis.mp4

Day 1 Treatment Challenges of Pulmonary Sarcoidosis.pdf

Day 2 After the ICU Post-ICU Care Syndrome and Recovery.pdf

Day 2 Approach to Empiric Antibiotics in the ICU.mp4

Day 2 Approach to Empiric Antibiotics in the ICU.pdf

Day 2 Approach to the Immunocompromised Critically Ill Patient.mp4

Day 2 Approach to the Immunocompromised Critically Ill Patient.pdf

Day 2 ARDS State-of-the-Art Strategies to Protect the Lung.pdf

Day 2 Fluid Responsiveness.mp4

Day 2 Fluid Responsiveness.pdf

Day 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.mp4

Day 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.pdf

Day 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.mp4

Day 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.pdf

Day 2 Novel Ventilator Modes The Hype and the Reality.mp4

Day 2 Novel Ventilator Modes The Hype and the Reality.pdf

Day 2 Q & A with Speakers 1.mp4

Day 2 Q & A with Speakers 2.mp4

Day 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).mp4

Day 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).pdf

Day 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.mp4

Day 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.pdf

Day 2 Vasopressors in Septic Shock Old Friends and New.mp4

Day 2 Vasopressors in Septic Shock Old Friends and New.pdf

Day 3 Advanced Cardiac Support in the ICU.mp4

Day 3 Advanced Cardiac Support in the ICU.pdf

Day 3 Common Neurologic Issues in the ICU.mp4

Day 3 Common Neurologic Issues in the ICU.pdf

Day 3 New Approaches to the Unexplained Chronic Cough.mp4

Day 3 New Approaches to the Unexplained Chronic Cough.pdf

Day 3 Occupational and Environmental Lung Disease.mp4

Day 3 Occupational and Environmental Lung Disease.pdf

Day 3 Palliative Care in Advanced Lung Disease.mp4

Day 3 Palliative Care in Advanced Lung Disease.pdf

Day 3 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care.pdf

Day 3 Point-of-Care Ultrasound in the Intensive Care Unit.pdf

Day 3 Prognosis and Uncertainty in the ICU.mp4

Day 3 Q & A with Speakers 1.mp4

Day 3 Q & A with Speakers 2.mp4

Day 3 Surgical Emergencies in the Medical ICU.mp4

Day 3 Surgical Emergencies in the Medical ICU.pdf

Day 3 The Microbiome and Lung Disease.mp4

Day 3 The Microbiome and Lung Disease.pdf

Day 3 TTM and Neuroprognostication After Cardiac Arrest.mp4

Day 3 TTM and Neuroprognostication After Cardiac Arrest.pdf

Day 4 A Strategic Approach to the Management of Pulmonary Nodules.pdf

Day 4 Aspergillus Lung Disease.mp4

Day 4 Aspergillus Lung Disease.pdf

Day 4 Asthma What’s New in 2025.mp4

Day 4 Asthma What’s New in 2025.pdf

Day 4 COPD 2025.mp4

Day 4 COPD 2025.pdf

Day 4 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond.mp4

Day 4 Interventional Pulmonology in 2025.mp4

Day 4 New Therapeutics in Lung Disease The Age of Immunotherapy.mp4

Day 4 New Therapeutics in Lung Disease The Age of Immunotherapy.pdf

Day 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.mp4

Day 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.pdf

Day 4 Pleural Disease 2025 Updates.mp4

Day 4 Pleural Disease 2025 Updates.pdf

Day 4 Q & A with Speakers 1.mp4

Day 4 Q & A with Speakers 2.mp4

Day 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies.pdf

Day 4 Tuberculosis in 2025.mp4

Day 4 Tuberculosis in 2025.pdf

Day 5 Complex Sleep Apnea 2025.pdf

Day 5 Noninvasive Ventilation.pdf

Day 5 Obstructive Sleep Apnea.pdf

Day 5 Pulmonary Embolism An Update.mp4

Day 5 Pulmonary Hypertension Categorization and Evaluation.mp4

Day 5 Pulmonary Hypertension Management.pdf

Day 5 Sleep Diagnostics.pdf

Day 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.mp4

Day 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.pdf

Day 5 Vasculitis and ANCA.mp4

Day 5 Vasculitis and ANCA.pdf

Day 5.mp4

Pulmonary Schedule.pdf